AXON Dx™

http://axondx.com/
Bio-manufacturing/Diagnostics | Devices/Instrumentation | Medical Technology
Bio-manufacturing/Diagnostics, Devices/Instrumentation, Medical Technology
  • Founded: 2013
  • CEO: Kent Murphy, PhD
  • Size of Facility: 10,000
  • Company Size: 15
  • Funding Source: Investor Funded
  • Development Stage: Pre-clinical

AXON Dx™ is developing instruments and reagents that allow rapid, minimally invasive analysis of the CTCs shed by the primary and metastatic tumors. With a simple blood draw, the researcher will be able to identify and count the CTCs in a patient’s sample.